Gilder Gagnon Howe & CO LLC Pulmonx Corp Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $29.9 Million - $45.4 Million	-1,006,299 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.98 - $44.48 $1.42 Million - $1.75 Million	-39,403 Reduced 3.77%	1,006,299 $36.2 Million
Q2 2021 Aug 16, 2021	SELL	$37.61 - $48.0 $98,500 - $125,712	-2,619 Reduced 0.25%	1,045,702 $46.1 Million
Q1 2021 May 17, 2021	SELL	$44.0 - $67.54 $2.39 Million - $3.67 Million	-54,281 Reduced 4.92%	1,048,321 $48 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $43.3 Million - $76.1 Million	1,102,602 New	1,102,602 $76.1 Million

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.